Company Profiles

driven by the PitchBook Platform

Amphivena Therapeutics

Description

Developer of therapeutic antibodies for the treatment of cancer and other diseases. The develops therapy that harnesses the patient's own immune system to destroy tumor cells and their precursors by allowing the antibodies to bind to target molecules on the surface of tumor cells, T-cells or NK-cells, leading to the breakdown of the cells.

2012

Founded

PRIVATE

Status

1-10

Employees

Series A

Latest Deal Type

$14M

Latest Deal Amount

$14M

Total Amount Raised

Description

Developer of therapeutic antibodies for the treatment of cancer and other diseases. The develops therapy that harnesses the patient's own immune system to destroy tumor cells and their precursors by allowing the antibodies to bind to target molecules on the surface of tumor cells, T-cells or NK-cells, leading to the breakdown of the cells.

Website:

www.amphivena.com

Formerly Known As

Affimed Spinco

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology

Primary Office

45 Juniper Street San Francisco, CA 94103United States
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Amphivena Therapeutics's full profile, request a free trial.

    Amphivena Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Amphivena Therapeutics Investors (4)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Affimed TherapeuticsCorporationMinority000 0000000 0000
    Calibrium (Pfäffikon)Family OfficeMinority000 0000000 0000
    EMBL VenturesVenture CapitalMinority000 0000000 0000
    MPM CapitalVenture CapitalMinority000 0000000 0000
    Affimed Therapeutics Corporation
    Calibrium (Pfäffikon) Family Office
    EMBL Ventures Venture Capital
    MPM Capital Venture Capital

    Amphivena Therapeutics Executive Team (2)

    NameTitleBoard
    Seat
    Contact
    Info
    Jeanmarie Guenot Ph.DPresident, Chief Executive Officer and Board Member
    Judith Fox Ph.DSenior Vice President, Research & Development
    Jeanmarie Guenot Ph.D President, Chief Executive Officer and Board Member
    Judith Fox Ph.D Senior Vice President, Research & Development

    Amphivena Therapeutics Board Members (4)

    NameRepresentingRoleSinceContact
    Info
    Adi Hoess MDAffimed TherapeuticsChief Executive Officer000 0000
    Florian Fischer Ph.DAffimed TherapeuticsChief Financial Officer000 0000
    Lori Kunkel MDSelfClinical Advisor & Board Member000 0000
    Luke Evnin Ph.DMPM CapitalCo-Founder & Managing Director000 0000
    Adi Hoess MD Chief Executive Officer Affimed Therapeutics
    Florian Fischer Ph.D Chief Financial Officer Affimed Therapeutics
    Lori Kunkel MD Clinical Advisor & Board Member Self
    Luke Evnin Ph.D Co-Founder & Managing Director MPM Capital
    Request full access to PitchBook